Post-kala-azar dermal leishmaniasis manifestation in a Mediterranean immunosuppressed patient: a rare incident

Clin Exp Dermatol. 2023 Jul 7;48(7):834-836. doi: 10.1093/ced/llad100.

Authors

Evdoxia Panou¹, Leonidas Marinos², Evangelia Piperaki³, Magda Migkou⁴, Alexander J Stratigos¹, Vasiliki Nikolaou¹

Affiliations

¹ 1st Dermatology Department, Andreas Syggros Hospital for Skin Diseases, National and Kapodistrian University of Athens Medical School, Athens, Greece.
² Department of Hematopathology, Evangelismos Hospital, Athens, Greece.
³ Department of Microbiology, National and Kapodistrian University of Athens, Greece.
⁴ Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

PMID: 36929204
DOI: 10.1093/ced/llad100

No abstract available

MeSH terms

Humans
Leishmania donovani*
Leishmaniasis, Cutaneous* / diagnosis
Leishmaniasis, Cutaneous* / drug therapy
Leishmaniasis, Visceral* / complications
Leishmaniasis, Visceral* / diagnosis